Immunotherapy has brought new hope for curing common cancers that have spread (metastatic) – once regarded as impossible. Over the last 10 years, immune checkpoint inhibitors – drugs that allow the immune system to identify and destroy previously unrecognised cancer cells – have been successfully used to treat melanoma, kidney cancer and lung cancer, among others. Clinicians are looking at whether vaccines, oncolytic viruses and cellular therapies could cure cancer. This lecture explores the scientific basis for this progress. This lecture was recorded by James Larkin on 15th February 2024 at Barnard's Inn Hall, London James is a Medical Oncologist specialising in the treatment of melanoma and cancers of the kidney. From 2022 he has led the Cancer Immunotherapy Theme at The Royal Marsden/Institute of Cancer Research NIHR Biomedical Research Centre.
Gresham College lecture by James Larkin
